Amedeo Smart

Free Medical Literature Service




  Free Subscription

Articles published in
    June 2024
  1. SABATINI S, Nolan JJ, O'Donoghue G, Kennedy A, et al
    Baseline phenotypes with preserved beta-cell function and high insulin concentrations have the best improvements in glucose tolerance after weight loss: results from the prospective DEXLIFE and EGIR-RISC studies.
    Metabolism. 2024;155:155910.
    >> Share

    May 2024
  2. LIAN LY, Targher G, Byrne CD, Liu WY, et al
    Resmetirom for MASH patients with diabetes: challenges and opportunities in the real world.
    Metabolism. 2024 May 15:155935. doi: 10.1016/j.metabol.2024.155935.
    >> Share

    April 2024
  3. JEREMIAH SS, Moin ASM, Butler AE
    Virus-induced diabetes mellitus, revisiting infection etiology in light of SARS-CoV-2.
    Metabolism. 2024 Apr 18:155917. doi: 10.1016/j.metabol.2024.155917.
    >> Share

  4. ROSENDO-SILVA D, Gomes PB, Rodrigues T, Viana S, et al
    Clinical and molecular profiling of human visceral adipose tissue reveals impairment of vascular architecture and remodeling as an early hallmark of dysfunction.
    Metabolism. 2024;153:155788.
    >> Share

    March 2024
  5. HE Y, Qu L
    The role and mechanisms of non-coding RNAs in diabetic peripheral neuropathy.
    Metabolism. 2024 Mar 8:155833. doi: 10.1016/j.metabol.2024.155833.
    >> Share

  6. HAN E, Lee BW, Kang ES, Cha BS, et al
    Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study.
    Metabolism. 2024;152:155789.
    >> Share

  7. LIU C, Zheng Y, Hu S, Liang X, et al
    TOX3 deficiency mitigates hyperglycemia by suppressing hepatic gluconeogenesis through FoxO1.
    Metabolism. 2024;152:155766.
    >> Share

  8. LAVILLE M, Robert M, Segrestin B
    Barriers to metabolic surgery and how to address them.
    Metabolism. 2024;152:155764.
    >> Share

  9. KE Z, Lu Z, Li Q, Tong W, et al
    Intestinal glucose excretion: A potential mechanism for glycemic control.
    Metabolism. 2024;152:155743.
    >> Share

    February 2024
  10. SARABHAI T, Kahl S, Gancheva S, Mastrototaro L, et al
    Loss of mitochondrial adaptation associates with deterioration of mitochondrial turnover and structure in metabolic dysfunction-associated steatotic liver disease.
    Metabolism. 2024;151:155762.
    >> Share

  11. TSILINGIRIS D, Kokkinos A
    Advances in obesity pharmacotherapy; learning from metabolic surgery and beyond.
    Metabolism. 2024;151:155741.
    >> Share

    January 2024
  12. PATEL S, Yan Z, Remedi MS
    Intermittent fasting protects beta-cell identity and function in a type-2 diabetes model.
    Metabolism. 2024 Jan 31:155813. doi: 10.1016/j.metabol.2024.155813.
    >> Share

  13. KIM J, Kim M, Kim M, You YH, et al
    Dysregulation of autophagy activation induced by atorvastatin contributes to new-onset diabetes mellitus in western diet-fed mice.
    Metabolism. 2024;153:155795.
    >> Share

  14. POPOVIC DS, Karakasis P, Koufakis T, Fragakis N, et al
    Effect of sodium-glucose cotransporter-2 inhibitors on continuous glucose monitoring metrics, as adjunctive to insulin in adults with type 1 diabetes mellitus: a meta-analysis of randomized controlled trials.
    Metabolism. 2024 Jan 15:155791. doi: 10.1016/j.metabol.2024.155791.
    >> Share

  15. KUGATHASAN L, Sridhar VS, Tommerdahl KL, Xu C, et al
    Minireview: Understanding and targeting inflammatory, hemodynamic and injury markers for cardiorenal protection in type 1 diabetes.
    Metabolism. 2024 Jan 10:155785. doi: 10.1016/j.metabol.2024.155785.
    >> Share

  16. YANG J, Yan Y, Yin X, Liu X, et al
    Bioengineering and vascularization strategies for islet organoids: advancing toward diabetes therapy.
    Metabolism. 2024 Jan 9:155786. doi: 10.1016/j.metabol.2024.155786.
    >> Share

  17. DIEPENBROEK C, Rijnsburger M, van Irsen AAS, Eggels L, et al
    Dopamine in the nucleus accumbens shell controls systemic glucose metabolism via the lateral hypothalamus and hepatic vagal innervation in rodents.
    Metabolism. 2024;150:155696.
    >> Share

    December 2023
  18. POPOVIC DS, Patoulias D, Gnudi L, Mantzoros CS, et al
    Diabetic kidney disease in type 1 diabetes: Challenges and differences from type 2 diabetes.
    Metabolism. 2023 Dec 18:155763. doi: 10.1016/j.metabol.2023.155763.
    >> Share

    November 2023
  19. ZUO F, Wang Y, Xu X, Ding R, et al
    CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease.
    Metabolism. 2023 Nov 10:155724. doi: 10.1016/j.metabol.2023.155724.
    >> Share

  20. PENG J, Lu M, Wang P, Peng Y, et al
    The global burden of metabolic disease in children and adolescents: Data from the Global Burden of Disease 2000-2019.
    Metabolism. 2023;148:155691.
    >> Share

    October 2023
  21. STEINBACH E, Masi D, Ribeiro A, Serradas P, et al
    Upper small intestine microbiome in obesity and related metabolic disorders: A new field of investigation.
    Metabolism. 2023 Oct 24:155712. doi: 10.1016/j.metabol.2023.155712.
    >> Share

  22. KARAKASIS P, Patoulias D, Pamporis K, Stachteas P, et al
    Safety and efficacy of the new, oral, small-molecule, GLP-1 receptor agonists orforglipron and danuglipron for the treatment of type 2 diabetes and obesity: systematic review and meta-analysis of randomized controlled trials.
    Metabolism. 2023 Oct 16:155710. doi: 10.1016/j.metabol.2023.155710.
    >> Share

  23. VAN JAD, Luo Y, Danska JS, Dai F, et al
    Postpartum defects in inflammatory response after gestational diabetes precede progression to type 2 diabetes: a nested case-control study within the SWIFT study.
    Metabolism. 2023 Oct 4:155695. doi: 10.1016/j.metabol.2023.155695.
    >> Share

    September 2023
  24. SHEN Y, Cheng L, Xu M, Wang W, et al
    SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis.
    Metabolism. 2023;146:155657.
    >> Share

  25. CHEN W, Cui W, Wu J, Zheng W, et al
    Blocking IL-6 signaling improves glucose tolerance via SLC39A5-mediated suppression of glucagon secretion.
    Metabolism. 2023;146:155641.
    >> Share

    August 2023
  26. SONG E, Hwang SY, Park MJ, Jang A, et al
    Additive impact of diabetes and sarcopenia on all-cause and cardiovascular mortality: A longitudinal nationwide population-based study.
    Metabolism. 2023 Aug 21:155678. doi: 10.1016/j.metabol.2023.155678.
    >> Share

    July 2023
  27. FERNANDEZ-SAEZ EM, Losarcos M, Becerril S, Valenti V, et al
    Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD.
    Metabolism. 2023 Jul 28:155663. doi: 10.1016/j.metabol.2023.155663.
    >> Share

  28. HU T, Wu Q, Yao Q, Yu J, et al
    PRDM16 exerts critical role in myocardial metabolism and energetics in type 2 diabetes induced cardiomyopathy.
    Metabolism. 2023 Jul 9:155658. doi: 10.1016/j.metabol.2023.155658.
    >> Share

    June 2023
  29. GOLABI P, Paik JM, Kumar A, Al Shabeeb R, et al
    Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States.
    Metabolism. 2023 Jun 26:155642. doi: 10.1016/j.metabol.2023.155642.
    >> Share

  30. JARVIS PRE, Cardin JL, Nisevich-Bede PM, McCarter JP, et al
    Continuous glucose monitoring in a healthy population: understanding the post-prandial glycemic response in individuals without diabetes mellitus.
    Metabolism. 2023 Jun 23:155640. doi: 10.1016/j.metabol.2023.155640.
    >> Share

  31. WEI F, Gu Y, He L, Kapoor A, et al
    HSD17B6 delays type 2 diabetes development via inhibiting SREBP activation.
    Metabolism. 2023;145:155631.
    >> Share

    May 2023
  32. HU J, Chen X, Luo Y, Yang J, et al
    Renin-independent aldosteronism and chronic kidney disease in diabetes: Observational and Mendelian randomization analyses.
    Metabolism. 2023;145:155593.
    >> Share

  33. PENG Y, Wang P, Gong J, Liu F, et al
    Association between the Finnish Diabetes Risk Score and cancer in middle-aged and older adults: Involvement of inflammation.
    Metabolism. 2023 May 8:155586. doi: 10.1016/j.metabol.2023.155586.
    >> Share

  34. HASHIMOTO Y, Takahashi F, Okamura T, Hamaguchi M, et al
    Diet, exercise, and pharmacotherapy for sarcopenia in people with diabetes.
    Metabolism. 2023 May 6:155585. doi: 10.1016/j.metabol.2023.155585.
    >> Share

  35. YU Q, Zhao G, Liu J, Peng Y, et al
    The role of histone deacetylases in cardiac energy metabolism in heart diseases.
    Metabolism. 2023;142:155532.
    >> Share

  36. CHEN X, Merovci A, DeFronzo RA, Tripathy D, et al
    Chronic physiologic hyperglycemia impairs insulin-mediated suppression of plasma glucagon concentration in healthy humans.
    Metabolism. 2023;142:155512.
    >> Share

    April 2023
  37. ZIEGLER D, Reiners K, Strom A, Obeid R, et al
    Association between diabetes and thiamine status - A systematic review and meta-analysis.
    Metabolism. 2023 Apr 22:155565. doi: 10.1016/j.metabol.2023.155565.
    >> Share

  38. CHONG B, Kong G, Shankar K, Chew HSJ, et al
    The global syndemic of metabolic diseases in the young adult population: A consortium of trends and projections from the Global Burden of Disease 2000-2019.
    Metabolism. 2023;141:155402.
    >> Share

    March 2023
  39. VEELEN A, Andriessen C, Op den Kamp Y, Erazo-Tapia E, et al
    Effects of the sodium-glucose cotransporter 2 inhibitor dapagliflozin on substrate metabolism in prediabetic insulin resistant individuals: A randomized, double-blind crossover trial.
    Metabolism. 2023;140:155396.
    >> Share

  40. GASBARRINO K, Hafiane A, Gianopoulos I, Zheng H, et al
    Relationship between circulating adipokines and cholesterol efflux in subjects with severe carotid atherosclerosis.
    Metabolism. 2023;140:155381.
    >> Share

    February 2023
  41. HWANG YC, Ahn HY, Jun JE, Jeong IK, et al
    Subtypes of type 2 diabetes and their association with outcomes in Korean adults - A cluster analysis of community-based prospective cohort.
    Metabolism. 2023;141:155514.
    >> Share

  42. YAN H, Meng Y, Li X, Xiang R, et al
    FAM3A maintains metabolic homeostasis by interacting with F1-ATP synthase to regulate the activity and assembly of ATP synthase.
    Metabolism. 2023;139:155372.
    >> Share

    January 2023
  43. BENEDICTE G, Sara F, Paul L, Laetitia N, et al
    Early humoral response to COVID-19 vaccination in patients living with obesity and diabetes in France. The COVPOP OBEDIAB study with results from the ANRS0001S COV-POPART cohort.
    Metabolism. 2023 Jan 30:155412. doi: 10.1016/j.metabol.2023.155412.
    >> Share

  44. ZHANG S, Stubbendorff A, Olsson K, Ericson U, et al
    Adherence to the EAT-Lancet diet, genetic susceptibility, and risk of type 2 diabetes in Swedish adults.
    Metabolism. 2023 Jan 19:155401. doi: 10.1016/j.metabol.2023.155401.
    >> Share

  45. DU F, Liu M, Wang J, Hu L, et al
    Metformin coordinates with mesenchymal cells to promote VEGF-mediated angiogenesis in diabetic wound healing through Akt/mTOR activation.
    Metabolism. 2023 Jan 7:155398. doi: 10.1016/j.metabol.2023.155398.
    >> Share

    December 2022
  46. LI S, Xu Z, Lin Z, Xiao H, et al
    Fyn deficiency inhibits oxidative stress by decreasing c-Cbl-mediated ubiquitination of Sirt1 to attenuate diabetic renal fibrosis.
    Metabolism. 2022 Dec 17:155378. doi: 10.1016/j.metabol.2022.155378.
    >> Share

  47. DU L, Chen Y, Shi J, Yu X, et al
    Inhibition of S100A8/A9 ameliorates renal interstitial fibrosis in diabetic nephropathy.
    Metabolism. 2022 Dec 12:155376. doi: 10.1016/j.metabol.2022.155376.
    >> Share

  48. ZHANG J, Wu Y, Zhang J, Zhang R, et al
    ABCA1 deficiency-mediated glomerular cholesterol accumulation exacerbates glomerular endothelial injury and dysfunction in diabetic kidney disease.
    Metabolism. 2022 Dec 12:155377. doi: 10.1016/j.metabol.2022.155377.
    >> Share

  49. WATKINS JD, Carter S, Atkinson G, Koumanov F, et al
    Glucagon-like peptide-1 secretion in people with versus without type 2 diabetes: a systematic review and meta-analysis of cross-sectional studies.
    Metabolism. 2022 Dec 8:155375. doi: 10.1016/j.metabol.2022.155375.
    >> Share

  50. LARSSON SC, Wang L, Li X, Jiang F, et al
    Circulating lipoprotein(a) levels and health outcomes: Phenome-wide Mendelian randomization and disease-trajectory analyses.
    Metabolism. 2022;137:155347.
    >> Share

  51. SANOUDOU D, Mantzoros CS, Hill MA
    Sodium-glucose cotransporter-2 inhibitors: A treatment option for recurrent vasovagal syndrome?
    Metabolism. 2022;137:155309.
    >> Share

    November 2022
  52. ANGELIDI AM, Kokkinos A, Sanoudou D, Connelly MA, et al
    Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity.
    Metabolism. 2022 Nov 11:155346. doi: 10.1016/j.metabol.2022.155346.
    >> Share

  53. LIU Z, Zhang L, Qian C, Zhou Y, et al
    Recurrent hypoglycemia increases hepatic gluconeogenesis without affecting glycogen metabolism or systemic lipolysis in rat.
    Metabolism. 2022;136:155310.
    >> Share

  54. YE J, Zhuang X, Li X, Gong X, et al
    Novel metabolic classification for extrahepatic complication of metabolic associated fatty liver disease: A data-driven cluster analysis with international validation.
    Metabolism. 2022;136:155294.
    >> Share

  55. MARKU A, Da Dalt L, Galli A, Dule N, et al
    Pancreatic PCSK9 controls the organization of the beta-cell secretory pathway via LDLR-cholesterol axis.
    Metabolism. 2022;136:155291.
    >> Share

  56. VALENZUELA-VALLEJO L, Guatibonza-Garcia V, Mantzoros CS
    Recent guidelines for Non-Alcoholic Fatty Liver disease (NAFLD)/ Fatty Liver Disease (FLD): Are they already outdated and in need of supplementation?
    Metabolism. 2022;136:155248.
    >> Share

    October 2022
  57. HUI Y, Xu Z, Li J, Kuang L, et al
    Nonenzymatic function of DPP4 promotes diabetes-associated cognitive dysfunction through IGF-2R/PKA/SP1/ERp29/IP3R2 pathway-mediated impairment of Treg function and M1 microglia polarization.
    Metabolism. 2022 Oct 24:155340. doi: 10.1016/j.metabol.2022.155340.
    >> Share

  58. LI X, Yang Y, Chen Z
    Downregulation of the m(6)A reader protein YTHDC1 leads to islet beta-cell failure and diabetes.
    Metabolism. 2022 Oct 24:155339. doi: 10.1016/j.metabol.2022.155339.
    >> Share

  59. DEMARSILIS A, Reddy N, Boutari C, Filippaios A, et al
    Pharmacotherapy of type 2 diabetes: An update and future directions.
    Metabolism. 2022 Oct 11:155332. doi: 10.1016/j.metabol.2022.155332.
    >> Share

  60. LAI H, Yang M, Sun M, Pan B, et al
    Risk of incident diabetes after COVID-19 infection: A systematic review and meta-analysis.
    Metabolism. 2022 Oct 8:155330. doi: 10.1016/j.metabol.2022.155330.
    >> Share

  61. LARSSON SC, Michaelsson K, Mola-Caminal M, Hoijer J, et al
    Genome-wide association and Mendelian randomization study of fibroblast growth factor 21 reveals causal associations with hyperlipidemia and possibly NASH.
    Metabolism. 2022;137:155329.
    >> Share

  62. LIU Z, Suo C, Fan H, Zhang T, et al
    Dissecting causal relationships between nonalcoholic fatty liver disease proxied by chronically elevated alanine transaminase levels and 34 extrahepatic diseases.
    Metabolism. 2022;135:155270.
    >> Share

  63. KAPRALOU AN, Chrousos GP
    Metabolic effects of truncal vagotomy when combined with bariatric-metabolic surgery.
    Metabolism. 2022;135:155263.
    >> Share

  64. DEMARSILIS A, Mantzoros CS
    The continuum of insulin development viewed in the context of a collaborative process toward leveraging science to save lives: Following the trail of publications and patents one century after insulin's first use in humans.
    Metabolism. 2022;135:155251.
    >> Share

    September 2022
  65. CHANG X, Li Y, Cai C, Wu F, et al
    Mitochondrial quality control mechanisms as molecular targets in diabetic heart.
    Metabolism. 2022 Sep 17:155313. doi: 10.1016/j.metabol.2022.155313.
    >> Share

  66. LEE M, Jeong K, Park YR, Rhee Y, et al
    Increased risk of incident diabetes after therapy with immune checkpoint inhibitor compared with conventional chemotherapy: A longitudinal trajectory analysis using a tertiary care hospital database.
    Metabolism. 2022 Sep 16:155311. doi: 10.1016/j.metabol.2022.155311.
    >> Share

  67. LIN CC, Li CI, Juan YL, Liu CS, et al
    Joint effect of blood pressure and glycemic variation on the risk of cardiovascular morbidity and mortality in persons with type 2 diabetes.
    Metabolism. 2022;136:155308.
    >> Share

  68. TRICO D, Mengozzi A, Baldi S, Bizzotto R, et al
    Lipid-induced glucose intolerance is driven by impaired glucose kinetics and insulin metabolism in healthy individuals.
    Metabolism. 2022;134:155247.
    >> Share

    August 2022
  69. WEN Y, Chen X, Feng H, Wang X, et al
    Kdm6a deficiency in microglia/macrophages epigenetically silences Lcn2 expression and reduces photoreceptor dysfunction in diabetic retinopathy.
    Metabolism. 2022 Aug 19:155293. doi: 10.1016/j.metabol.2022.155293.
    >> Share

  70. BAUMANN A, Burger K, Brandt A, Staltner R, et al
    GW9662, a peroxisome proliferator-activated receptor gamma antagonist, attenuates the development of non-alcoholic fatty liver disease.
    Metabolism. 2022;133:155233.
    >> Share

  71. KOUFAKIS T, Popovic DS, Metallidis S, Kotsa K, et al
    COVID-19 and sulfonylureas: A reminder of the pleiotropic actions of an old class of drugs just before their swansong.
    Metabolism. 2022;133:155221.
    >> Share

  72. TRIGGLE CR, Mohammed I, Bshesh K, Marei I, et al
    Metformin: Is it a drug for all reasons and diseases?
    Metabolism. 2022;133:155223.
    >> Share

    July 2022
  73. SAVIKJ M, Stocks B, Sato S, Caidahl K, et al
    Exercise timing influences multi-tissue metabolome and skeletal muscle proteome profiles in type 2 diabetic patients - A randomized crossover trial.
    Metabolism. 2022 Jul 28:155268. doi: 10.1016/j.metabol.2022.155268.
    >> Share

    June 2022
  74. LUO Q, Liang W, Zhang Z, Zhu Z, et al
    Compromised glycolysis contributes to foot process fusion of podocytes in diabetic kidney disease: Role of ornithine catabolism.
    Metabolism. 2022 Jun 30:155245. doi: 10.1016/j.metabol.2022.155245.
    >> Share

  75. SARDU C, Massimo Massetti M, Rambaldi P, Gatta G, et al
    SGLT2-inhibitors reduce the cardiac autonomic neuropathy dysfunction and vaso-vagal syncope recurrence in patients with type 2 diabetes mellitus: the SCAN study.
    Metabolism. 2022 Jun 19:155243. doi: 10.1016/j.metabol.2022.155243.
    >> Share

  76. VERMA M, Loh NY, Sabaratnam R, Vasan SK, et al
    TCF7L2 plays a complex role in human adipose progenitor biology, which might contribute to genetic susceptibility to type 2 diabetes.
    Metabolism. 2022 Jun 10:155240. doi: 10.1016/j.metabol.2022.155240.
    >> Share

  77. CAO Q, Zheng R, He R, Wang T, et al
    Use of the new guidelines on an earlier age threshold of 35years for diabetes screening can identify an additional 6.3 million undiagnosed individuals with diabetes and 72.3 million individuals with prediabetes among Chinese adults: An analysis of a n
    Metabolism. 2022 Jun 10:155238. doi: 10.1016/j.metabol.2022.155238.
    >> Share

  78. XU C, Li H, Tang CK
    Sterol carrier protein 2 in lipid metabolism and non-alcoholic fatty liver disease: Pathophysiology, molecular biology, and potential clinical implications.
    Metabolism. 2022;131:155180.
    >> Share

  79. ZHAO Y, Jia X, Yang X, Bai X, et al
    Deacetylation of Caveolin-1 by Sirt6 induces autophagy and retards high glucose-stimulated LDL transcytosis and atherosclerosis formation.
    Metabolism. 2022;131:155162.
    >> Share

    May 2022
  80. JEPSEN MR, Ostergaard JA, Conover CA, Wogensen L, et al
    Increased activity of the metalloproteinase PAPP-A promotes diabetes-induced glomerular hypertrophy.
    Metabolism. 2022 May 16:155218. doi: 10.1016/j.metabol.2022.155218.
    >> Share

  81. XU C, Hou Y, Si K, Cao Z, et al
    Cardiorespiratory fitness, genetic susceptibility, inflammation and risk of incident type 2 diabetes: A population-based longitudinal study.
    Metabolism. 2022 May 16:155215. doi: 10.1016/j.metabol.2022.155215.
    >> Share

    April 2022
  82. UM JH, Park SY, Hur JH, Lee HY, et al
    Bone morphogenic protein 9 is a novel thermogenic hepatokine secreted in response to cold exposure.
    Metabolism. 2022;129:155139.
    >> Share

    March 2022
  83. NGUYEN NN, Ho DS, Nguyen HS, Ho DKN, et al
    Preadmission use of antidiabetic medications and mortality among patients with COVID-19 having type 2 diabetes: A meta-analysis.
    Metabolism. 2022;131:155196.
    >> Share

  84. YAO L, Liang X, Qiao Y, Chen B, et al
    Mitochondrial dysfunction in diabetic tubulopathy.
    Metabolism. 2022;131:155195.
    >> Share

  85. YANG T, Heng C, Zhou Y, Hu Y, et al
    Corrigendum to 'Targeting mammalian serine/threonine-protein kinase 4 through yes-associated protein/TEA domain transcription factor-mediated epithelial-mesenchymal transition ameliorates diabetic nephropathy orchestrated renal fibrosis [Metabolism Cl
    Metabolism. 2022;130:154963.
    >> Share

  86. CHEN Y, Yang Y, Liu Z, He L, et al
    Adiponectin promotes repair of renal tubular epithelial cells by regulating mitochondrial biogenesis and function.
    Metabolism. 2022;128:154959.
    >> Share

  87. MAGKOS F, Lee MH, Lim M, Cook AR, et al
    Dynamic assessment of insulin secretion and insulin resistance in Asians with prediabetes.
    Metabolism. 2022;128:154957.
    >> Share

    February 2022
  88. HUANG S, Wang J, Zhang L, Tian S, et al
    Ras guanine nucleotide-releasing protein-4 promotes renal inflammatory injury in type 2 diabetes mellitus.
    Metabolism. 2022 Feb 23:155177. doi: 10.1016/j.metabol.2022.155177.
    >> Share

  89. SCHERNTHANER G, Brand K, Bailey CJ
    Metformin and the heart: Update on mechanisms of cardiovascular protection with special reference to comorbid type 2 diabetes and heart failure.
    Metabolism. 2022 Feb 7:155160. doi: 10.1016/j.metabol.2022.155160.
    >> Share

  90. WARE J, Hovorka R
    Recent advances in closed-loop insulin delivery.
    Metabolism. 2022;127:154953.
    >> Share

  91. FALCETTA P, Aragona M, Bertolotto A, Bianchi C, et al
    Insulin discovery: A pivotal point in medical history.
    Metabolism. 2022;127:154941.
    >> Share

  92. CARUSO I, Giorgino F
    SGLT-2 inhibitors as cardio-renal protective agents.
    Metabolism. 2022;127:154937.
    >> Share

    January 2022
  93. QU HQ, Qu J, Glessner J, Hakonarson H, et al
    Mendelian randomization study of obesity and type 2 diabetes in hospitalized COVID-19 patients.
    Metabolism. 2022 Jan 28:155156. doi: 10.1016/j.metabol.2022.155156.
    >> Share

  94. ZHENG W, Guo J, Lu X, Qiao Y, et al
    cAMP-response element binding protein mediates podocyte injury in diabetic nephropathy by targeting lncRNA DLX6-AS1.
    Metabolism. 2022 Jan 27:155155. doi: 10.1016/j.metabol.2022.155155.
    >> Share

  95. LEE J, Han K, Park SH, Kim MK, et al
    Associations of variability in body weight and glucose levels with the risk of hip fracture in people with diabetes.
    Metabolism. 2022 Jan 12:155135. doi: 10.1016/j.metabol.2022.155135.
    >> Share

  96. BOLLI GB, Porcellati F, Lucidi P, Fanelli CG, et al
    One-hundred year evolution of prandial insulin preparations: From animal pancreas extracts to rapid-acting analogs.
    Metabolism. 2022;126:154935.
    >> Share

  97. CHU X, Raju RP
    Regulation of NAD(+) metabolism in aging and disease.
    Metabolism. 2022;126:154923.
    >> Share

  98. ROSENSTOCK J, Del Prato S
    Basal weekly insulins: the way of the future!
    Metabolism. 2022;126:154924.
    >> Share

  99. LO T, Lee Y, Tseng CY, Hu Y, et al
    Daily transient coating of the intestine leads to weight loss and improved glucose tolerance.
    Metabolism. 2022;126:154917.
    >> Share

    December 2021
  100. THOMAS MC
    The clustering of Cardiovascular, Renal, Adipo-Metabolic and Liver disease with type 2 diabetes.
    Metabolism. 2021 Dec 24:154961. doi: 10.1016/j.metabol.2021.154961.
    >> Share

  101. CORNEJO MA, Ortiz RM
    Body mass cycling and predictors of body mass regain and its impact on cardiometabolic health.
    Metabolism. 2021;125:154912.
    >> Share

  102. MASTROTOTARO L, Roden M
    Insulin resistance and insulin sensitizing agents.
    Metabolism. 2021;125:154892.
    >> Share

    November 2021
  103. ZHOU C, Zhang Z, Liu M, Zhang Y, et al
    Corrigendum to 'Dietary carbohydrate intake and new-onset diabetes: A Nationwide Cohort Study in China' [Metab Clin Exp 123 (2021) 154865].
    Metabolism. 2021;127:154940.
    >> Share

  104. MARFELLA R, D'Onofrio N, Trotta MC, Sardu C, et al
    Sodium/glucose cotransporter 2 (SGLT2) inhibitors improve cardiac function by reducing JunD expression in human diabetic hearts.
    Metabolism. 2021;127:154936.
    >> Share

  105. HOME P
    Future directions in insulin therapy.
    Metabolism. 2021;124:154889.
    >> Share

  106. WEIR GC, Butler PC, Bonner-Weir S
    The beta-cell glucose toxicity hypothesis: Attractive but difficult to prove.
    Metabolism. 2021;124:154870.
    >> Share

    October 2021
  107. KOWLURU RA, Mohammad G
    Epigenetic modifications in diabetes.
    Metabolism. 2021 Oct 26:154920. doi: 10.1016/j.metabol.2021.154920.
    >> Share

  108. ZHAO Z, Deng X, Jia J, Zhao L, et al
    Angiopoietin-like protein 8 (betatrophin) inhibits hepatic gluconeogenesis through PI3K/Akt signaling pathway in diabetic mice.
    Metabolism. 2021 Oct 26:154921. doi: 10.1016/j.metabol.2021.154921.
    >> Share

  109. LIU H, Sridhar VS, Boulet J, Dharia A, et al
    Cardiorenal protection with SGLT2 inhibitors in patients with diabetes mellitus: from biomarkers to clinical outcomes in heart failure and diabetic kidney disease.
    Metabolism. 2021 Oct 23:154918. doi: 10.1016/j.metabol.2021.154918.
    >> Share

  110. ZHANG Y, Cai Y, Zhang H, Zhang J, et al
    Brown adipose tissue transplantation ameliorates diabetic nephropathy through the miR-30b pathway by targeting Runx1.
    Metabolism. 2021 Oct 16:154916. doi: 10.1016/j.metabol.2021.154916.
    >> Share

  111. JANKAUSKAS SS, Kansakar U, Varzideh F, Wilson S, et al
    Heart failure in diabetes.
    Metabolism. 2021 Oct 7:154910. doi: 10.1016/j.metabol.2021.154910.
    >> Share

    September 2021
  112. RIZZO M, Nauck MA, Mantzoros CS
    Incretin-based therapies in 2021 - Current status and perspectives for the future.
    Metabolism. 2021;122:154843.
    >> Share

  113. ZHANG X, Zhuang Y, Qin T, Chang M, et al
    Suppressor of cytokine signalling-2 controls hepatic gluconeogenesis and hyperglycemia by modulating JAK2/STAT5 signalling pathway.
    Metabolism. 2021;122:154823.
    >> Share

    August 2021
  114. LANDRY T, Shookster D, Huang H
    Circulating alpha-klotho regulates metabolism via distinct central and peripheral mechanisms.
    Metabolism. 2021;121:154819.
    >> Share

    July 2021
  115. ARVIND A, Memel ZN, Philpotts LL, Zheng H, et al
    Thiazolidinediones, alpha-glucosidase inhibitors, meglitinides, sulfonylureas, and hepatocellular carcinoma risk: A meta-analysis.
    Metabolism. 2021;120:154780.
    >> Share

    August 2020
  116. ZHU Z, Hasegawa K, Ma B, Fujiogi M, et al
    Obesity & genetic predisposition with COVID-19.
    Metabolism. 2020 Aug 21:154345. doi: 10.1016/j.metabol.2020.154345.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016